+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Effect of rifampicin induced S9 fraction on the mutagenicity of isoniazid in the Salmonella assay system

Effect of rifampicin induced S9 fraction on the mutagenicity of isoniazid in the Salmonella assay system

Indian Journal of Medical Research 86: 232-236

(PDF emailed within 1 workday: $29.90)

Accession: 039939347

Download citation: RISBibTeXText

PMID: 3428956

Related references

Effect of the rat liver S9 fraction on the mutagenicity of azathioprine in the Salmonella/mammalian microsome assay. Experientia 40(4): 370-371, 1984

Evaluation of the therapeutic system 2 isoniazid rifampicin streptomycin pyrazinamide 4 isoniazid 2 rifampicin 2 in bacilliferous pulmonary tuberculosis in the adult. Revista Argentina de Tuberculosis Enfermedades Pulmonares y Salud Publica 47(3): 33-39, 1986

Ursolic acid inhibits aflatoxin B1-induced mutagenicity in a Salmonella assay system. Biological & Pharmaceutical Bulletin 17(7): 990-992, 1994

The therapeutic effect of regimens containing isoniazid and rifampicin for pulmonary tuberculosis with single isoniazid or rifampicin resistance. Zhonghua Jie He He Hu Xi Za Zhi 37(12): 915-918, 2015

Potentiation of isoniazid-induced liver toxicity by rifampicin in a combinational therapy of antitubercular drugs (rifampicin, isoniazid and pyrazinamide) in Wistar rats: A toxicity profile study. Hepatology Research 37(10): 845-853, 2007

Effect of dietary casein levels on activation of promutagens in the spiral Salmonella mutagenicity assay. II. Studies with induced rat liver S9. Mutation Research 360(2): 127-143, 1996

Mutagenicity of bi-, tri- and tetra-cyclic aromatic hydrocarbons in the "taped-plate assay" and in the conventional salmonella mutagenicity assay. Mutation Research 204(2): 203-206, 1988

Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System. Annals of Laboratory Medicine 38(6): 569-577, 2018

Evaluation of the mutagenic carcinogenic potential of medicinal by the salmonella microsomal fraction assay i. mutagenicity of anti trypanosoma cruzi drugs. Ciencia e Cultura (Sao Paulo) 38(4): 696-702, 1986

Evaluation of the mutagenic-carcinogenic potential of medicines using the Salmonella/microsomal fraction assay. I. Mutagenicity of anti-Trypanosoma cruzi drugs. Ciencia e Cultura 38(4): 696-702, 1986

Synergistic effect of diethylstilbestrol on the mutagenicity of 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene in the Salmonella assay system. Cancer Letters 7(2-3): 109-114, 1979

Effects of the hepatic S9 fraction from aroclor-1254-treated rats on the mutagenicity of benzo[alpha]pyrene and 2-aminoanthracene in the Salmonella/microsome assay. Mutation Research 64(6): 379-389, 1979

A case of rifampicin-induced acute renal failure and review of 47 cases with liver dysfunction induced by isoniazid and rifampicin. Kekkaku 56(7): 375-378, 1981

Effects of the hepatic s 9 fraction from aroclor 1254 treated rats on the mutagenicity of benzo a pyrene and 2 amino anthracene in the salmonella typhimurium microsome assay. Mutation Research 64(6): 379-390, 1979

Tailored release drug delivery system for rifampicin and isoniazid for enhanced bioavailability of rifampicin. Pharmaceutical Development and Technology 16(2): 127-136, 2011